Art
J-GLOBAL ID:200902181370706251
Reference number:01A0662503 Combination of N-Methyl-1-Deoxynojirimycin and Ischemic Preconditioning Markedly Reduces the Size of Myocardial Infarcts in Rabbits.
ウサギにおいてN-メチル-1-デオキシノジリマイシンと虚血プレコンディショニングの組み合わせは心筋梗塞のサイズを顕著に減少させる
- 1. Li YW, Whittaker P, Kloner RA: The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmia. Am Heart J 1992; 123: 346-353
- 2. Thornton J, Strriplin S, Liu GS, Swafford A, Stanley AW, Van Winkel DM, et al: Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning. Am J Physiol 1990; 259: H1822-H1825
- 3. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136
- 4. Schott RJ, Rohmann S, Braun ER, Schaper W: Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 1990; 66: 1133-1142
- 5. Nakagawa Y, Ito H, Kitakaze M, Kusuoka H, Hori M, Kuzuya T, et al: Effect of angina pectoris on myocardial protection in patients with reperfused anterior wall myocardial infarction: Retrospective clinical evidence of `preconditioning'. J Am Coll Cardiol 1995; 25: 1076-1083
- 6. Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, Downey JM: Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 1991; 84: 350-356
- 7. Kariya T, Minatoguchi S, Ohno T, Yamashita K, Uno Y, Arai M, et al: Infarct size-reducing effect of ischemic preconditioning is related to α1b-adrenoceptors but not to α1a-adrenoceptors in rabbits. J Cardiovasc Pharmacol 1997; 30: 437-445
- 8. Goto M, Liu Y, Yang Xi-M, Ardell JL, Cohen MV, Downey JM: Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 1995; 77: 611-621
- 9. Tanaka M, Fujiwara H, Yamasaki K, Sasayama S: Superoxide dismutase and N-2-mercaptopropionyl glycine attenuate infarct size limitation effect of ischemic preconditioning in the rabbit. Cardiovasc Res 1994; 28: 980-986
- 10. Ytrehus K, Liu Y, Downey JM: Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994; 266: H1145-H1152
- 11. Gross GJ, Auchampach JA: Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992; 70: 223-233
- 12. Kida M, Fujiwara H, Ishida M, Kawai C, Ohura M, Miura I, et al: Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation 1991; 84: 2495-2503
- 13. Jennings RB, Murry CE, Reimer KA: Energy metabolism in preconditioned and control myocardium: Effect of total ischemia. J Mol Cell Cardiol 1991; 23: 1449-1458
- 14. Murry CE, Richard VJ, Reimer KA, Jennings RB: Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 1990; 66: 913-931
- 15. Arai M, Minatoguchi S, Takemura G, Uno Y, Kariya T, Takatsu H, et al: N-methyl-1-deoxynojirimycin (MOR-14), an α-glucosidase inhibitor, markedly reduced infarct size in rabbit hearts. Circulation 1998; 97: 1290-1297
- 16. Fishbein MC, Meerbaum S, Rit J, Lando U, Kanmatsuse K, Mercier JC, et al: Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 1981; 101: 593-600
- 17. Keppler W, Decker K: Methods of enzymatic analysis. New York: Academic Press Inc, 1984: 11-18
- 18. Bergmyer HU: Methods of enzymatic Analysis. New York: Academic Press Inc, 1974: 1446-1451
- 19. Harken AH, Simson MB, Haselgrove J, Westein L, Harden WR, Barlow CH: Early ischemia after complete coronary ligation in the rabbit, dog, pig, and monkey. Am J Physiol 1981; 241: H202-H210
- 20. Bollen M, Stalmans W: The antiglycogenolytic action of 1-deoxynojirimycin results from a specific inhibition of the α-1,6-glucosidase activity of the debranching enzyme. Eur J Biochem 1989; 181: 775-780
Return to Previous Page